With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.23462-75-1,Dihydro-2H-pyran-3(4H)-one,as a common compound, the synthetic route is as follows.
To a solution of dihydro-2H-pyran-3(4H)-one (100 mg, 1.0 mmol) in dry THF (10 mL) was added lithium bis(trimethylsilyl)amide (1.2 mL, 1.2 mmol, 1M in THF) at 0 C. After stirring for 5 min, i-9 (260 mg, 1.2 mmol) was added and stirred for additional 5 min. Acetic acid (1 mL) was added followed by addition of hydrazine monohydrate (1 mL, 85%). The reaction was quenched with aqueous NaHCO3 and the mixture was extracted with EtOAc. The combined organic layers were washed with saturated brine, dried over Na2SO4 and concentrated. The residue was purified by prep TLC (EtOAc/PE=1:1) to give the title compound. LCMS (ESI) calc’d for C14H13FN2O3[M+H]+: 277, found: 277., 23462-75-1
The synthetic route of 23462-75-1 has been constantly updated, and we look forward to future research findings.
Reference£º
Patent; Merck Sharp & Dohme Corp.; Lapointe, Blair T.; Fuller, Peter H.; Gunaydin, Hakan; Liu, Kun; Sciammetta, Nunzio; Trotter, Benjamin Wesley; Zhang, Hongjun; Barr, Kenneth J.; Maclean, John K. F.; Molinari, Danielle F.; Simov, Vladimir; (103 pag.)US2018/16239; (2018); A1;,
Tetrahydropyran – Wikipedia
Tetrahydropyran – an overview | ScienceDirect Topics